SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-022004
Filing Date
2022-12-23
Accepted
2022-12-23 17:40:12
Documents
2
Period of Report
2022-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3790
2 POWER OF ATTORNEY poa.htm EX-24.1 3015
  Complete submission text file 0001567619-22-022004.txt   8485
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AYTU BIOSCIENCE, INC. 373 INVERNESS PARKWAY, SUITE 200 ENGLEWOOD CO 80112
Business Address
Donofrio John Jr. (Reporting) CIK: 0001679841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 221486243